Key News
1. People's Bank of China: Will continue to implement a moderately loose monetary policy and increase counter-cyclical and cross-cyclical adjustments.
2. People's Bank of China: Conducted 400 billion yuan MLF operation on December 25.
3. The US concludes the previous administration's investigation into Chinese chip trade, and will not impose additional tariffs on Chinese chips for the next 18 months.
4. Beijing: Beijing-registered families with multiple children can buy up to three homes within the Fifth Ring Road; the minimum down payment ratio has been adjusted from no less than 30% to no less than 25%.
5. Financial support accelerates the construction of the Western Land-Sea New Corridor; eight departments jointly released 21 measures.
Individual Stock News
1. CATL's Yichun Jianxiawo lithium mine is expected to resume production around the Spring Festival.
2. Fenglong Shares: The controlling shareholder is planned to change to UBTECH, the world's first listed humanoid robot company; the stock will resume trading on the 25th.
3. Lianchuang Electronics: The actual controller is planned to change to the Jiangxi Provincial State-owned Assets Supervision and Administration Commission; the stock will resume trading on the 25th. 4. Hainan Development (4 consecutive daily limit-up): Has not entered the aerospace satellite materials business and has not received any related business orders.
5. Anfu Technology: Suzhou Yilan Microelectronics has developed a unique silicon photonics heterogeneous integrated thin-film lithium niobate technology platform, which is the optimal solution for the evolution of silicon photonics platforms.
6. Sungrow Power: Four shareholders collectively reduced their holdings by 423,700 shares, of which Wu Jiamao terminated his reduction plan early and still holds 1,200 shares.
7. Sega Technology: The capital increase of Guangcai Xinchen has been approved by more than 2/3 of the target company's shareholders.
8. Shengtong Energy (9 consecutive daily limit-up): If the stock price rises further in the future, it may apply to the Shenzhen Stock Exchange for a trading suspension for investigation.
9. Hongda Electronics: The IPO of its investee company Jiangsu Zhanxin will not have a significant impact on the current financial statements.
10. Hengrui Medicine: Injectable SHR-A1904 has been included in the list of breakthrough therapy products; currently, there are no similar products approved for marketing globally.
11. Huaqin Technology: Signed a 254 million yuan contract for special functional materials for aircraft fuselages.
